Maze Therapeutics, Inc. · NASDAQ:MAZE

Coloma Jason V sold 1,938 Maze Therapeutics, Inc. shares (Form 4)

Traded May 15, 2026 · Filed May 18, 2026

On May 15, 2026, Coloma Jason V (Director, Chief Executive Officer) sold 1,938 Maze Therapeutics, Inc. shares at US$26.00 for US$50,388 under a trading plan, leaving 31,001 shares. Filed May 18, 2026 (Form 4).

Sold
1,938 shares
Price
US$26.00
Value
US$50,388
Holding after
31,001 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 15, 2026Common StockSale1,822US$26.00381,073Indirect
May 15, 2026Common StockSale116US$26.0031,001Indirect

Source

View original at SEC

Related